No Data
No Data
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $5
Heron Gains on FDA Nod for New Zynrelef Application
Express News | Heron Therapeutics Inc - Van Expected to Launch in Q4 2024
Express News | Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle ("Van")
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF Vial Access Needle ("VAN")
No Data
No Data
Fomo Mofo : this setup is not ideal for me. it doesn't meet all the requirements in my checklist. will watch when markets open but doubtful I will trade it.
HannChau OP Fomo Mofo : you seems right , don't have much buying pressure in premarket
Fomo Mofo HannChau OP : as much as I hate no trade days, I get major fomo, its still better than making a poor choice and having a red day. I'm really not seeing anything today yet that fits my strategy.
IDKWTFIMDOING : Doesn't look hot to me yet.
HannChau OP IDKWTFIMDOING : indeed, looks horrible now
View more comments...